期刊文献+

微循环功能障碍或衰竭在心力衰竭发病机制中的推理认识 被引量:2

The Reasoning Relation between the Microcirculation Dysfunction and Heart Failure
下载PDF
导出
摘要 心力衰竭是导致人类死亡的主要疾病之一,目前尚无有效的治愈方法。心力衰竭的发生有多种病因,但导致心力衰竭的基本病理变化是心肌细胞水肿、变性、坏死和纤维化,病理生理变化是心脏扩大、收缩力下降、每搏量和心排血量降低。发生这些变化的基础是体循环、脏器循环和微循环功能出现不同程度障碍,进而形成恶性循环最终导致心力衰竭的发生。基于此理论提出临床心衰治疗模式的转变和深思,目的是进一步提高心力衰竭疗效和改革医学教育模式。 Heart failure is an important disease causing people death. At present there is no good effective method to cure it. Many etiological factors can cause heart failure. But the basic pathologic changes of heart failure are myocardium edema, denaturation, putrescence and fibrosis. The main pathophysiological changes are heart expanding, contractive force descending, LVSV and cardiac output lowering. The foundation of that is the different dysfunction of body circulation, organ circulation and microcirculation. Thus vicious circle of those factors at last brings about heart failure. Basing on this theory the change of curing mode and recognition about heart failure is proposed. The aim is further to improve effectiveness of heart failure and to reform medical education pattern.
出处 《医学综述》 2009年第2期225-227,共3页 Medical Recapitulate
关键词 微循环障碍 心力衰竭 发病机制 Mierocirculation dysfunction Heart failure Pathogenesis
  • 相关文献

参考文献14

  • 1卡茨,马爱群.心力衰竭[M].北京:人民卫生出版社,2004:60-320.
  • 2Beohar N, Erdogan AK, Lee DC, et al. Acute heart failure syndromes and coronary peffusion [ J ]. J Am Coll Cardiol, 2008,52 (1) :13-16.
  • 3Nanas S, Gerovasili V, Dimopoulos S, et al. Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure[ J ]. J Card Fail ,2008,14 ( 5 ) :400-406.
  • 4O'Rourke MF. Arterial aging: pathophysiological principles [ J ]. Vase Med ,2007,12(4) :329-341.
  • 5Den Uil CA, Klijn E, Lagrand WK, et al. The microcirculation in health and critical disease[J]. Prog Cardiovasc Dis,2008,51 (2) : 161-170.
  • 6Aneja A, Tang WH, Bansilal S, et al. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options[ J ]. Am J Med ,2008,121 (9) :748-757.
  • 7Beohar N, Erdogan AK, Lee DC, et al. Acute heart failure syndromes and coronary perfusion [J]. J Am Coll Cardiol, 2008,52 (1) :13-16.
  • 8Kubrich M, Petrakopoulou P, Kofler S, et al. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation[ J ]. Transplantation ,2008,85 ( 11 ) : 1580-1587.
  • 9Yamashita K, Tasaki H. Intracoronary administration of isosorbide dinitrate induced severely slow flow and transient ST-segment elevation [ J ]. Angiology ,2008,59 ( 3 ) : 379-381.
  • 10Ikonomidis I, Parissis JT, Paraskevaidis I, et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure [ J ]. Eur J Heart Fail, 2007,9 ( 12 ) : 1172-1177.

二级参考文献17

  • 1Liu PP, Mak S, Stewart DJ. Potential roles of the microvasclature in progression of heart failure. Am J Cardiol, 1999, 84: 23L-26L.
  • 2Wei Zheng, Brown MD, Brock TA, et al. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res, 1999, 85:192-198.
  • 3John R, Teerlink JM, Pfeffer MA, et al. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res, 1994,75:105-113.
  • 4Isabelle L, Emesto LS. Cardiac microvasculature in DOAC-salt hypertensive rats. Effect of endothelin ETA receptor antagonism. Hypertension, 1999, 34:795-801.
  • 5Komaru T, Kanatsuka H, Shirato K. Coronary microcirculation: physiology and pharmacology. Pharmacol Ther, 2000, 86 (3): 217-261.
  • 6Chilian WM. Functional distribution of alpha sub 1 -and alpha sub 2 -adrenergic receptors in the coronary microcirculation. Circulation, 1991, 84:2108-2122.
  • 7Prasad A, Higano ST, A1 Suwaidi J, et al. Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction. Am Heart J, 2003, 146:549-554.
  • 8Boer RA, Pinio YM, Suurmeijer AJ, et al. Increased expression of cardiac angiotensin Ⅱ type 1 (AT (1))receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc Res,2003, 57:434-442.
  • 9Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochern Biophys Res Commun, 1993,195:1005-1010.
  • 10Torry RJ, O' Brien DM, Connell PM, et al. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. J Phyisol Heart Circ Physiol, 1992,269:1312-1318.

共引文献2

同被引文献13

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部